Cargando…
Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19
Coronavirus disease 2019 (COVID-19) is the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2; SC2), which has caused a worldwide pandemic with striking morbidity and mortality. Evaluation of SC2 strains demonstrated impressive genetic variability, and many of these viral...
Autores principales: | Kamle, Suchitra, Ma, Bing, Lee, Chang Min, Schor, Gail, Zhou, Yang, Lee, Chun Geun, Elias, Jack A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273216/ https://www.ncbi.nlm.nih.gov/pubmed/35735790 http://dx.doi.org/10.7554/eLife.78273 |
Ejemplares similares
-
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
por: Lee, Suh-Young, et al.
Publicado: (2022) -
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19
por: Kamle, Suchitra, et al.
Publicado: (2021) -
Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease
por: Zhang, Songhua, et al.
Publicado: (2021) -
Pressure-driven release of viral genome into a host nucleus is a mechanism leading to herpes infection
por: Brandariz-Nuñez, Alberto, et al.
Publicado: (2019) -
Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants
por: Greenwood, Edward JD, et al.
Publicado: (2016)